NCT02569723 2021-03-30
Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy
University of California, Davis
Phase NA Completed
University of California, Davis
Fox Chase Cancer Center
Albert Einstein College of Medicine
Georgetown University
Memorial Sloan Kettering Cancer Center